Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its boronic acid functionality enables Suzuki-Miyaura cross-coupling reactions, facilitating the construction of complex biaryl structures in drug molecules. Commonly employed in medicinal chemistry for optimizing lead compounds due to its ability to enhance binding affinity and metabolic stability. Also utilized in the preparation of proteolysis-targeting chimeras (PROTACs) and other bifunctional molecules where precise molecular assembly is critical.